BMP-1/tolloid-like proteinases synchronize matrix assembly with growth factor activation to promote morphogenesis and tissue remodeling

Matrix Biology

Volumn 44-46, Issue , 2015, Pages 14-23

  Vadon Le Goff, Sandrine ^a   Hulmes, David J S ^a   Moali, Catherine ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Bone morphogenetic protein; Collagen; Fibrosis; Metalloproteinase; Osteogenesis imperfecta; TGF

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; BIGLYCAN; BONE MORPHOGENETIC PROTEIN 4; CHORDIN; FIBRONECTIN; FRIZZLED PROTEIN; GROWTH FACTOR; PROCOLLAGEN; PROCOLLAGEN C PROTEINASE; SOMATOMEDIN BINDING PROTEIN 3; TOLLOID METALLOPROTEINASE; TRANSCRIPTION FACTOR RUNX2; ANGIOGENESIS INHIBITOR; BMP1 PROTEIN, HUMAN; SCLEROPROTEIN; SIGNAL PEPTIDE;

AMINO TERMINAL SEQUENCE; BONE DENSITY; BONE DISEASE; CARBOXY TERMINAL SEQUENCE; COLLAGEN FIBRIL; CONFORMATIONAL TRANSITION; ELASTICITY; EXTRACELLULAR MATRIX; GLYCOSYLATION; HEART MUSCLE FIBROSIS; HUMAN; LIVER FIBROSIS; MORPHOGENESIS; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CLEAVAGE; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TENSILE STRENGTH; TISSUE REPAIR; TRIPLE HELIX; TUMOR GROWTH; ANIMAL; METABOLISM; REGENERATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BONE MORPHOGENETIC PROTEIN 1; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MORPHOGENESIS; REGENERATION;

EID: 84930765783     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2015.02.006     Document Type: Review

References (108)

1. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
2. Sterchi E.E., Stocker W., Bond J.S. Meprins, membrane-bound and secreted astacin metalloproteinases. Mol Aspects Med 2008, 29:309-328.
3. Shimell M.J., Ferguson E.L., Childs S.R., O'Connor M.B. The Drosophila dorsal-ventral patterning gene tolloid is related to human bone morphogenetic protein 1. Cell 1991, 67:469-481.
4. Takahara K., Lyons G.E., Greenspan D.S. Bone morphogenetic protein-1 and a mammalian tolloid homologue (mTld) are encoded by alternatively spliced transcripts which are differentially expressed in some tissues. J Biol Chem 1994, 269:32572-32578.
5. Muir A., Greenspan D.S. Metalloproteinases in Drosophila to humans that are central players in developmental processes. J Biol Chem 2011, 286:41905-41911.
6. Suzuki N., Labosky P.A., Furuta Y., Hargett L., Dunn R., Fogo A.B., et al. Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila tolloid. Development 1996, 122:3587-3595.
7. Clark T.G., Conway S.J., Scott I.C., Labosky P.A., Winnier G., Bundy J., et al. The mammalian tolloid-like 1 gene, Tll1, is necessary for normal septation and positioning of the heart. Development 1999, 126:2631-2642.
8. Wermter C., Howel M., Hintze V., Bombosch B., Aufenvenne K., Yiallouros I., et al. The protease domain of procollagen C-proteinase (BMP1) lacks substrate selectivity, which is conferred by non-proteolytic domains. Biol Chem 2007, 388:513-521.
9. MacSweeney A., Gil-Parrado S., Vinzenz D., Bernardi A., Hein A., Bodendorf U., et al. Structural basis for the substrate specificity of bone morphogenetic protein 1/tolloid-like metalloproteases. J Mol Biol 2008, 384:228-239.
10. Berry R., Jowitt T.A., Ferrand J., Roessle M., Grossmann J.G., Canty-Laird E.G., et al. Role of dimerization and substrate exclusion in the regulation of bone morphogenetic protein-1 and mammalian tolloid. Proc Natl Acad Sci U S A 2009, 106:8561-8566.
11. Berry R., Jowitt T.A., Garrigue-Antar L., Kadler K.E., Baldock C. Structural and functional evidence for a substrate exclusion mechanism in mammalian tolloid like-1 (TLL-1) proteinase. FEBS Lett 2010, 584:657-661.
12. Kessler E., Takahara K., Biniaminov L., Brusel M., Greenspan D.S. Bone morphogenetic protein-1: the type I procollagen C-proteinase. Science 1996, 271:360-362.
13. Li S.W., Sieron A.L., Fertala A., Hojima Y., Arnold W.V., Prockop D.J. The C-proteinase that processes procollagens to fibrillar collagens is identical to the protein previously identified as bone morphogenic protein-1. Proc Natl Acad Sci U S A 1996, 93:5127-5130.
14. Hojima Y., Behta B., Romanic A.M., Prockop D.J. Cleavage of type I procollagen by C- and N-proteinases is more rapid if the substrate is aggregated with dextran sulfate or polyethylene glycol. Anal Biochem 1994, 223:173-180.
15. Hojima Y., van der Rest M., Prockop M.J. Type I procollagen carboxyl-terminal proteinase from chick embryo tendons. J Biol Chem 1985, 260:15996-16003.
16. Broder C., Arnold P., Vadon-Le Goff S., Konerding M.A., Bahr K., Muller S., et al. Metalloproteases meprin alpha and meprin beta are C- and N-procollagen proteinases important for collagen assembly and tensile strength. Proc Natl Acad Sci U S A 2013, 110:14219-14224.
17. Kronenberg D., Bruns B.C., Moali C., Vadon-Le Goff S., Sterchi E.E., Traupe H., et al. Processing of procollagen III by meprins: new players in extracellular matrix assembly?. J Invest Dermatol 2010, 130:2727-2735.
18. Steiglitz B.M., Kreider J.M., Frankenburg E.P., Pappano W.N., Hoffman G.G., Meganck J.A., et al. Procollagen C proteinase enhancer 1 genes are important determinants of the mechanical properties and geometry of bone and the ultrastructure of connective tissues. Mol Cell Biol 2006, 26:238-249.
19. Gopalakrishnan B., Wang W.M., Greenspan D.S. Biosynthetic processing of the Pro-alpha1(V)Pro-alpha2(V)Pro-alpha3(V) procollagen heterotrimer. J Biol Chem 2004, 279:30904-30912.
20. Imamura Y., Steiglitz B.M., Greenspan D.S. Bone morphogenetic protein-1 processes the NH2-terminal propeptide, and a furin-like proprotein convertase processes the COOH-terminal propeptide of pro-alpha1(V) collagen. J Biol Chem 1998, 273:27511-27517.
21. Kessler E., Fichard A., Chanut-Delalande H., Brusel M., Ruggiero F. Bone morphogenetic protein-1 (BMP-1) mediates C-terminal processing of procollagen V homotrimer. J Biol Chem 2001, 276:27051-27057.
22. Pappano W.N., Steiglitz B.M., Scott I.C., Keene D.R., Greenspan D.S. Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases. Mol Cell Biol 2003, 23:4428-4438.
23. Linsenmayer T.F., Gibney E., Igoe F., Gordon M.K., Fitch J.M., Fessler L.I., et al. Type V collagen: molecular structure and fibrillar organization of the chicken alpha 1(V) NH2-terminal domain, a putative regulator of corneal fibrillogenesis. J Cell Biol 1993, 121:1181-1189.
24. Ge G., Seo N.S., Liang X., Hopkins D.R., Hook M., Greenspan D.S. Bone morphogenetic protein-1/tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis. J Biol Chem 2004, 279:41626-41633.
25. Scott I.C., Imamura Y., Pappano W.N., Troedel J.M., Recklies A.D., Roughley P.J., et al. Bone morphogenetic protein-1 processes probiglycan. J Biol Chem 2000, 275:30504-30511.
26. von Marschall Z., Fisher L.W. Decorin is processed by three isoforms of bone morphogenetic protein-1 (BMP1). Biochem Biophys Res Commun 2010, 391:1374-1378.
27. Rattenholl A., Pappano W.N., Koch M., Keene D.R., Kadler K.E., Sasaki T., et al. Proteinases of the bone morphogenetic protein-1 family convert procollagen VII to mature anchoring fibril collagen. J Biol Chem 2002, 277:26372-26378.
28. Amano S., Scott I.C., Takahara K., Koch M., Champliaud M.F., Gerecke D.R., et al. Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma2 chain. J Biol Chem 2000, 275:22728-22735.
29. Veitch D.P., Nokelainen P., Mcgowan K.A., Nguyen T.T., Nguyen N.E., Stephenson R., et al. Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. J Biol Chem 2003, 278:15661-15668.
30. Bachy S., Letourneur F., Rousselle P. Syndecan-1 interaction with the LG4/5 domain in laminin-332 is essential for keratinocyte migration. J Cell Physiol 2008, 214:238-249.
31. Kagan H.M., Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 2003, 88:660-672.
32. Borel A., Eichenberger D., Farjanel J., Kessler E., Gleyzal C., Hulmes D.J.S., et al. Lysyl oxidase-like protein from bovine aorta. Isolation and maturation to an active form by bone morphogenetic protein-1. J Biol Chem 2001, 276:48944-48949.
33. Cronshaw A.D., Fothergillgilmore L.A., Hulmes D.J.S. The proteolytic processing site of the precursor of lysyl oxidase. Biochem J 1995, 306:279-284.
34. Panchenko M.V., Stetlerstevenson W.G., Trubetskoy O.V., Gacheru S.N., Kagan H.M. Metalloproteinase activity secreted by fibrogenic cells in the processing of prolysyl oxidase-potential role of procollagen C- proteinase. J Biol Chem 1996, 271:7113-7119.
35. Baker A.M., Bird D., Lang G., Cox T.R., Erler J.T. Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK. Oncogene 2013, 32:1863-1868.
36. Steiglitz B.M., Ayala M., Narayanan K., George A., Greenspan D.S. Bone morphogenetic protein-1/Tolloid-like proteinases process dentin matrix protein-1. J Biol Chem 2004, 279:980-986.
37. Tsuchiya S., Simmer J.P., Hu J.C., Richardson A.S., Yamakoshi F., Yamakoshi Y. Astacin proteases cleave dentin sialophosphoprotein (Dspp) to generate dentin phosphoprotein (Dpp). J Bone Miner Res 2011, 26:220-228.
38. von Marschall Z., Fisher L.W. Dentin sialophosphoprotein (DSPP) is cleaved into its two natural dentin matrix products by three isoforms of bone morphogenetic protein-1 (BMP1). Matrix Biol 2010, 29:295-303.
39. Lee S.B., Solow-Cordero D.E., Kessler E., Takahara K., Greenspan D.S. Transforming growth factor-beta regulation of bone morphogenetic protein-1 procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes. J Biol Chem 1997, 272:19059-19066.
40. Tovar-Vidales T., Fitzgerald A.M., Clark A.F., Wordinger R.J. Transforming growth factor-beta2 induces expression of biologically active bone morphogenetic protein-1 in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2013, 54:4741-4748.
41. Moustakas A., Heldin C.H. Induction of epithelial-mesenchymal transition by transforming growth factor beta. Semin Cancer Biol 2012, 22:446-454.
42. Ge G., Greenspan D.S. BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. J Cell Biol 2006, 175:111-120.
43. Delolme F., Anastasi C., Alcaraz L.B., Mendoza V., Vadon-Le Goff S., Talantikite M., et al. Proteolytic control of TGF-beta co-receptor activity by BMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics. Cell Mol Life Sci 2015, 72:1009-1027.
44. Ge G., Hopkins D.R., Ho W.B., Greenspan D.S. GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells. Mol Cell Biol 2005, 25:5846-5858.
45. Wolfman N.M., McPherron A.C., Pappano W.N., Davies M.V., Song K., Tomkinson K.N., et al. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci U S A 2003, 100:15842-15846.
46. Marques G., Musacchio M., Shimell M.J., Wunnenberg-Stapleton K., Cho K.W.Y., O'Connor M.B. Production of a DPP activity gradient in the early drosophila embryo through the opposing actions of the SOG and TLD proteins. Cell 1997, 91:417-426.
47. Piccolo S., Agius E., Lu B., Goodman S., Dale L., De Robertis E.M. Cleavage of chordin by xolloid metalloproteinase suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell 1997, 91:407-416.
48. Kim B., Huang G., Ho W.B., Greenspan D.S. Bone morphogenetic protein-1 processes insulin-like growth factor-binding protein 3. J Biol Chem 2011, 286:29014-29025.
49. Gonzalez E.M., Reed C.C., Bix G., Fu J., Zhang Y., Gopalakrishnan B., et al. BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J Biol Chem 2005, 280:7080-7087.
50. Ge G., Fernandez C.A., Moses M.A., Greenspan D.S. Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor. Proc Natl Acad Sci U S A 2007, 104:10010-10015.
51. Nguyen N.Q., Tabruyn S.P., Lins L., Lion M., Cornet A.M., Lair F., et al. Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis. Proc Natl Acad Sci U S A 2006, 103:14319-14324.
52. Odagiri H., Kadomatsu T., Endo M., Masuda T., Morioka M.S., Fukuhara S., et al. The secreted protein ANGPTL2 promotes metastasis of osteosarcoma cells through integrin alpha5beta1, p38 MAPK, and matrix metalloproteinases. Sci Signal 2014, 7:ra7.
53. Maertens B., Hopkins D., Franzke C.W., Keene D.R., Bruckner-Tuderman L., Greenspan D.S., et al. Cleavage and oligomerization of gliomedin, a transmembrane collagen required for node of ranvier formation. J Biol Chem 2007, 282:10647-10659.
54. Chau P., Fielding P.E., Fielding C.J. Bone morphogenetic protein-1 (BMP-1) cleaves human proapolipoprotein A1 and regulates its activation for lipid binding. Biochemistry 2007, 46:8445-8450.
55. Adar R., Kessler E., Goldberg B. Evidence for a protein that enhances the activity of type I procollagen C-proteinase. Coll Relat Res 1986, 6:267-277.
56. Kessler E., Adar R. Type I procollagen C-proteinase from mouse fibroblasts. Eur J Biochem 1989, 186:115-121.
57. Bourhis J.M., Vadon-Le Goff S., Afrache H., Mariano N., Kronenberg D., Thielens N.M., et al. Procollagen C-proteinase enhancer grasps the stalk of the C-propeptide trimer to boost collagen precursor maturation. Proc Natl Acad Sci U S A 2013, 110:6394-6399.
58. Hulmes D.J.S., Mould A.P., Kessler E. The CUB domains of procollagen C-proteinase enhancer control collagen assembly solely by their effect on procollagen C- proteinase/bone morphogenetic protein-1. Matrix Biol 1997, 16:41-45.
59. Kronenberg D., Vadon-Le Goff S., Bourhis J.M., Font B., Eichenberger D., Hulmes D.J.S., et al. Strong cooperativity and loose geometry between CUB domains are the basis for procollagen c-proteinase enhancer activity. J Biol Chem 2009, 284:33437-33446.
60. Takahara K., Kessler E., Biniaminov L., Brusel M., Eddy R.L., Janisait S., et al. Type I procollagen COOH-terminal proteinase enhancer protein: Identification, primary structure, and chromosomal localization of the cognate human gene (PCOLCE). J Biol Chem 1994, 269:26280-26285.
61. Bekhouche M., Kronenberg D., Vadon-Le Goff S., Bijakowski C., Lim N.H., Font B., et al. Role of the NTR domain of procollagen C-proteinaser enhancer-1 in the control of metalloproteinase activity. J Biol Chem 2010, 285:15950-15959.
62. Weiss T., Ricard-Blum S., Moschcovich L., Wineman E., Mesilaty S., Kessler E. Binding of procollagen C-proteinase enhancer-1 (PCPE-1) to heparin/heparan sulfate: properties and role in PCPE-1 interaction with cells. J Biol Chem 2010, 285:33867-33874.
63. Vadon-Le Goff S., Kronenberg D., Bourhis J.M., Bijakowski C., Raynal N., Ruggiero F., et al. Procollagen C-proteinase enhancer stimulates procollagen processing by binding to the C-propeptide only. J Biol Chem 2011, 286:38932-38938.
64. Moali C., Font B., Ruggiero F., Eichenberger D., Rousselle P., Francois V., et al. Substrate-specific modulation of a multisubstrate proteinase. C-terminal processing of fibrillar procollagens is the only BMP-1-dependent activity to be enhanced by PCPE-1. J Biol Chem 2005, 280:24188-24194.
65. Petropoulou V., Garrigue-Antar L., Kadler K.E. Identification of the minimal domain structure of bone morphogenetic protein-1 (BMP-1) for chordinase activity: chordinase activity is not enhanced by procollagen C-proteinase enhancer-1 (PCPE-1). J Biol Chem 2005, 280:22616-22623.
66. Symoens S., Renard M., Bonod-Bidaud C., Syx D., Vaganay E., Malfait F., et al. Identification of binding partners interacting with the alpha1-N-propeptide of type V collagen. Biochem J 2011, 433:371-381.
67. Xu H., Acott T.S., Wirtz M.K. Identification and expression of a novel type I procollagen C- proteinase enhancer protein gene from the glaucoma candidate region on 3q21-q24. Genomics 2000, 66:264-273.
68. Steiglitz B.M., Keene D.R., Greenspan D.S. PCOLCE2 encodes a functional procollagen C-proteinase enhancer (PCPE2) that is a collagen-binding protein differing in distribution of expression and post-translational modification from the previously described PCPE1. J Biol Chem 2002, 277:49820-49830.
69. Zhu J., Gardner J., Pullinger C.R., Kane J.P., Thompson J.F., Francone O.L. Regulation of apoAI processing by procollagen C-proteinase enhancer-2 and bone morphogenetic protein-1. J Lipid Res 2009, 50:1330-1339.
70. Francone O.L., Ishida B.Y., de la Llera-Moya M., Royer L., Happe C., Zhu J., et al. Disruption of the murine procollagen C-proteinase enhancer 2 causes accumulation of pro-apolipoprotein A-I and increased HDL levels. J Lipid Res 2011, 52:1974-1983.
71. Yamaguchi Y. Periostin in skin tissue and skin-related diseases. Allergol Int 2014, 63:161-170.
72. Liu A.Y., Zheng H., Ouyang G. Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments. Matrix Biol 2014, 37:150-156.
73. Norris R.A., Damon B., Mironov V., Kasyanov V., Ramamurthi A., Moreno-Rodriguez R., et al. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem 2007, 101:695-711.
74. Maruhashi T., Kii I., Saito M., Kudo A. Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. J Biol Chem 2010, 285:13294-13303.
75. Fogelgren B., Polgar N., Szauter K.M., Ujfaludi Z., Laczko R., Fong K.S., et al. Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. J Biol Chem 2005, 280:24690-24697.
76. Huang G., Zhang Y., Kim B., Ge G., Annis D.S., Mosher D.F., et al. Fibronectin binds and enhances the activity of bone morphogenetic protein 1. J Biol Chem 2009, 284:25879-25888.
77. Inomata H., Haraguchi T., Sasai Y. Robust stability of the embryonic axial pattern requires a secreted scaffold for chordin degradation. Cell 2008, 134:854-865.
78. Scott I.C., Blitz I.L., Pappano W.N., Maas S.A., Cho K.W., Greenspan D.S. Homologues of twisted gastrulation are extracellular cofactors in antagonism of BMP signalling. Nature 2001, 410:475-478.
79. Sun M., Forsman C., Sergi C., Gopalakrishnan R., O'Connor M.B., Petryk A. The expression of twisted gastrulation in postnatal mouse brain and functional implications. Neuroscience 2010, 169:920-931.
80. Miljkovic-Licina M., Hammel P., Garrido-Urbani S., Lee B.P., Meguenani M., Chaabane C., et al. Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage. Mol Cancer Ther 2012, 11:2588-2599.
81. Zhang Y., Ge G., Greenspan D.S. Inhibition of bone morphogenetic protein 1 by native and altered forms of alpha2-macroglobulin. J Biol Chem 2006, 281:39096-39104.
82. Grgurevic L., Macek B., Healy D.R., Brault A.L., Erjavec I., Cipcic A., et al. Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis. J Am Soc Nephrol 2011, 22:681-692.
83. Lee H.X., Ambrosio A.L., Reversade B., De Robertis E.M. Embryonic dorsal-ventral signaling: secreted frizzled-related proteins as inhibitors of tolloid proteinases. Cell 2006, 124:147-159.
84. Muraoka O., Shimizu T., Yabe T., Nojima H., Bae Y.K., Hashimoto H., et al. Sizzled controls dorso-ventral polarity by repressing cleavage of the Chordin protein. Nat Cell Biol 2006, 8:329-338.
85. Ploper D., Lee H.X., De Robertis E.M. Dorsal-ventral patterning: crescent is a dorsally secreted Frizzled-related protein that competitively inhibits Tolloid proteases. Dev Biol 2011, 352:317-328.
86. He W., Zhang L., Ni A., Zhang Z., Mirotsou M., Mao L., et al. Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proc Natl Acad Sci U S A 2010, 107:21110-21115.
87. Kobayashi K., Luo M., Zhang Y., Wilkes D.C., Ge G., Grieskamp T., et al. Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat Cell Biol 2009, 11:46-55.
88. Bijakowski C., Vadon-Le Goff S., Delolme F., Bourhis J.M., Lecorche P., Ruggiero F., et al. Sizzled is unique among secreted Frizzled-related proteins for its ability to specifically inhibit bone morphogenetic protein-1 (BMP-1)/Tolloid-like proteinases. J Biol Chem 2012, 287:33581-33593.
89. Lee H.X., Mendes F.A., Plouhinec J.L., De Robertis E.M. Enzymatic regulation of pattern: BMP4 binds CUB domains of Tolloids and inhibits proteinase activity. Genes Dev 2009, 23:2551-2562.
90. Jasuja R., Ge G., Voss N.G., Lyman-Gingerich J., Branam A.M., Pelegri F.J., et al. Bone morphogenetic protein 1 prodomain specifically binds and regulates signaling by bone morphogenetic proteins 2 and 4. J Biol Chem 2007, 282:9053-9062.
91. Reid R.R., Mogford J.E., Butt R., deGiorgio-Miller A., Mustoe T.A. Inhibition of procollagen C-proteinase reduces scar hypertrophy in a rabbit model of cutaneous scarring. Wound Repair Regen 2006, 14:138-141.
92. Wong V.W., You F., Januszyk M., Gurtner G.C., Kuang A.A. Transcriptional profiling of rapamycin-treated fibroblasts from hypertrophic and keloid scars. Ann Plast Surg 2014, 72:711-719.
93. Malecaze F., Massoudi D., Fournie P., Tricoire C., Cassagne M., Malbouyres M., et al. Upregulation of bone morphogenetic protein-1/mammalian tolloid and procollagen C-proteinase enhancer-1 in corneal scarring. Invest Ophthalmol Vis Sci 2014, 55:6712-6721.
94. Ogata I., Auster A.S., Matsui A., Greenwel P., Geerts A., D'Amico T., et al. Up-regulation of type I procollagen C-proteinase enhancer protein messenger RNA in rats with CCl4-induced liver fibrosis. Hepatology 1997, 26:611-617.
95. Kessler-Icekson G., Schlesinger H., Freimann S., Kessler E. Expression of procollagen C-proteinase enhancer-1 in the remodeling rat heart is stimulated by aldosterone. Int J Biochem Cell Biol 2006, 38:358-365.
96. Baicu C.F., Zhang Y., Van Laer A.O., Renaud L., Zile M.R., Bradshaw A.D. Effects of the absence of procollagen C-endopeptidase enhancer-2 on myocardial collagen accumulation in chronic pressure overload. Am J Physiol Heart Circ Physiol 2012, 303:H234-H240.
97. Beaumont J., Lopez B., Hermida N., Schroen B., San J.G., Heymans S., et al. microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-beta1 up-regulation. Clin Sci (Lond) 2014, 126:497-506.
98. Lindahl K., Barnes A.M., Fratzl-Zelman N., Whyte M.P., Hefferan T.E., Makareeva E., et al. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat 2011, 32:598-609.
99. Asharani P.V., Keupp K., Semler O., Wang W., Li Y., Thiele H., et al. Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. Am J Hum Genet 2012, 90:661-674.
100. Martinez-Glez V., Valencia M., Caparros-Martin J.A., Aglan M., Temtamy S., Tenorio J., et al. Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat 2012, 33:343-350.
101. Valencia M., Caparros-Martin J.A., Sirerol-Piquer M.S., Garcia-Verdugo J.M., Martinez-Glez V., Lapunzina P., et al. Report of a newly indentified patient with mutations in BMP1 and underlying pathogenetic aspects. Am J Med Genet A 2014, 164A:1143-1150.
102. Hoyer-Kuhn H., Semler O., Schoenau E., Roschger P., Klaushofer K., Rauch F. Hyperosteoidosis and hypermineralization in the same bone: bone tissue analyses in a boy with a homozygous BMP1 mutation. Calcif Tissue Int 2013, 93:565-570.
103. Muir A.M., Ren Y., Butz D.H., Davis N.A., Blank R.D., Birk D.E., et al. Induced ablation of Bmp1 and Tll1 produces osteogenesis imperfecta in mice. Hum Mol Genet 2014, 23:3085-3101.
104. Naba A., Clauser K.R., Lamar J.M., Carr S.A., Hynes R.O. Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters. Elife 2014, 3:e01308.
105. Torres S., Bartolome R.A., Mendes M., Barderas R., Fernandez-Acenero M.J., Pelaez-Garcia A., et al. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer. Clin Cancer Res 2013, 19:6006-6019.
106. Wu X., Liu T., Fang O., Leach L.J., Hu X., Luo Z. miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27(kip1). Oncogene 2014, 33:1506-1514.
107. Newman A.C., Nakatsu M.N., Chou W., Gershon P.D., Hughes C.C. The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Mol Biol Cell 2011, 22:3791-3800.
108. Syx D., Guillemyn B., Symoens S., Sousa A.B., Medeira A., Whiteford M., et al. Defective proteolytic processing of fibrillar procollagens and prodecorin due to bi-allelic BMP-1 mutations results in a severe, progressive form of osteogenesis imperfecta. J Bone Miner Res 2015, [in press].